SpringWorks and GSK sign clinical trial collaboration agreement

SpringWorks Therapeutics has signed an agreement to assess its nirogacestat in combination with GlaxoSmithKline’s belantamab mafodotin to treat patients with relapsed or refractory multiple myeloma.

EMA Validates Santheras Marketing Authorization Application for Puldysain Duchenne Muscular

The initiation of the CHMP review of our application is an important milestone for patients with DMD who currently have no alternative treatment for the preservation...

Verona Pharma Strengthens its Clinical Team Ahead of Phase 3 Development of Ensifentrine

Verona Pharma plc announces two senior appointments to its clinical team. They will lead the Phase 3 program for Verona Pharma’s first-in-class ...

Pharmaceutical packaging: Advantages of digital printing technology in blister packaging

Producing pharmaceutical products for the global market is hugely challenging and complex. When a drug is set to be sold in multiple countries, it needs to be packaged in a way which accommodates the regulatory requirements.

Velabs announces 3M Series B Financing to Advance its Functional Antibody Screening Programme

Velabs Therapeutics announced the closing of a €3 million Series B financing round to advance its functional antibody screening programme and to strengthen...

Priorclave laboratory Launches New Autoclave Controller

All laboratory autoclaves and research sterilisers leaving the Priorclave design and manufacturing centre in the UK are now fitted with a new, technologically advanced controller.

For Advertising Queries:

Please e-mail : kathryn@worldpharmatoday.com
or
call to: + 91 88268 49084

If you like to receive our latest Media Pack / Editorial Calendar please click here

For the latest visit: www.worldpharmatoday.com